Consistent with the aforementioned studies, our investigation revealed significant correlations between platelet antibody presence, number of platelet transfusions, fever, splenomegaly, bleeding, and infection (as clinical indicators) and platelet preservation time, IL-6, p62, and BECN1 (as AP-related indicators) with the effectiveness of platelet transfusion in ALL patients. Here, IL6 is linked to acute lymphoblastic leukemia.